HDAC9 and acute lymphoblastic leukemia: HDAC9 is a direct transcriptional target of MEF2 and acts to inhibit the transcriptional activity of MEF2C9, consistent with the striking downregulation of this gene in MEF2D-rearranged ALL (Supplementary Data 3–5 and Supplementary Figs 14 and 15).